FACCHINETTI, ANTONELLA
 Distribuzione geografica
Continente #
NA - Nord America 284
AS - Asia 64
EU - Europa 48
Totale 396
Nazione #
US - Stati Uniti d'America 283
CN - Cina 32
SG - Singapore 29
IT - Italia 27
FI - Finlandia 7
RU - Federazione Russa 5
DE - Germania 3
FR - Francia 3
HK - Hong Kong 2
CA - Canada 1
IE - Irlanda 1
IN - India 1
NL - Olanda 1
SE - Svezia 1
Totale 396
Città #
Fairfield 36
Chandler 33
Houston 26
Ann Arbor 22
Singapore 18
Ashburn 16
Cambridge 16
Seattle 15
Wilmington 14
Padova 11
Woodbridge 11
Santa Clara 10
Boardman 9
Beijing 7
San Diego 7
New York 6
Princeton 5
Helsinki 4
Medford 3
Turin 3
Arzignano 2
Guangzhou 2
Hong Kong 2
Indiana 2
Nanjing 2
Ogden 2
Selvazzano Dentro 2
Amsterdam 1
Casaletto 1
Chiampo 1
Clifton 1
Dallas 1
Des Moines 1
Dublin 1
Frankfurt am Main 1
Fuyang 1
Fuzhou 1
Hebei 1
Los Angeles 1
Milan 1
Norwalk 1
Pune 1
Shenyang 1
Tianjin 1
Verona 1
Washington 1
Totale 305
Nome #
Retaining the long-survive capacity of Circulating Tumor Cells (CTCs) followed by xeno-transplantation: not only from metastatic cancer of the breast but also of prostate cancer patients. 104
Immune response to Moloney-murine leukemia virus-induced antigens in bone marrow 97
Functional avidity-driven activation-induced cell death shapes CTL immunodominance. 70
Clinical significance of circulating tumor cells and cell-free DNA in pediatric rhabdomyosarcoma 66
Investigating the Retained Inhibitory Effect of Cobimetinib against p.P124L Mutated MEK1: A Combined Liquid Biopsy and in Silico Approach 26
Methylation Markers in Cutaneous Melanoma: Unravelling the Potential Utility of Their Tracking by Liquid Biopsy 23
Investigating the Retained Inhibitory Effect of Cobimetinib against p.P124L Mutated MEK1: A Combined Liquid Biopsy and in Silico Approach 19
Totale 405
Categoria #
all - tutte 2.098
article - articoli 2.098
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.196


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202027 0 0 0 0 0 0 4 8 7 5 2 1
2020/202121 3 1 0 1 1 2 0 6 3 1 2 1
2021/202260 0 5 8 4 1 2 2 8 6 5 6 13
2022/202369 8 9 2 14 9 11 0 5 4 1 4 2
2023/202464 2 6 7 6 6 11 12 0 2 1 7 4
2024/202574 1 15 12 13 21 12 0 0 0 0 0 0
Totale 405